Overview
Shingo Imanishi practices in Toyama, Japan. Mr. Imanishi is rated as an Advanced expert by MediFind in the treatment of IgG4-Related Disease. His top areas of expertise are IgG4-Related Disease, Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), and Small Cell Lung Cancer (SCLC).
His clinical research consists of co-authoring 26 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- IgG4-Related DiseaseMr. Imanishi isAdvanced. Learn about IgG4-Related Disease.
- Experienced
- AsthmaMr. Imanishi isExperienced. Learn about Asthma.
- Breast CancerMr. Imanishi isExperienced. Learn about Breast Cancer.
- Esophageal CancerMr. Imanishi isExperienced. Learn about Esophageal Cancer.
- Gastrointestinal Stromal TumorMr. Imanishi isExperienced. Learn about Gastrointestinal Stromal Tumor.
- Lung CancerMr. Imanishi isExperienced. Learn about Lung Cancer.
- Non-Small Cell Lung Cancer (NSCLC)Mr. Imanishi isExperienced. Learn about Non-Small Cell Lung Cancer (NSCLC).